|
FKBP8 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.8751004061719E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12009999450902E-08 |
| Normal-vs-Stage2 |
1.013540E-02 |
| Normal-vs-Stage3 |
6.11839999997699E-07 |
| Normal-vs-Stage4 |
1.89784999999887E-05 |
| Stage1-vs-Stage2 |
8.124400E-01 |
| Stage1-vs-Stage3 |
2.617800E-01 |
| Stage1-vs-Stage4 |
7.836100E-02 |
| Stage2-vs-Stage3 |
3.614400E-01 |
| Stage2-vs-Stage4 |
1.340150E-01 |
| Stage3-vs-Stage4 |
3.610400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3860000076279E-09 |
| Normal-vs-AfricanAmerican |
4.835900E-03 |
| Normal-vs-Asian |
1.60248999999668E-05 |
| Caucasian-vs-AfricanAmerican |
5.820400E-01 |
| Caucasian-vs-Asian |
1.360800E-01 |
| AfricanAmerican-vs-Asian |
6.532600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17730000193106E-08 |
| Normal-vs-Female |
2.25840000034339E-08 |
| Male-vs-Female |
7.658200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.5901000000903E-07 |
| Normal-vs-Age(41-60Yrs) |
1.41000000564162E-09 |
| Normal-vs-Age(61-80Yrs) |
1.992870E-04 |
| Normal-vs-Age(81-100Yrs) |
8.773900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.205800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.365400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.254200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.285200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.592200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.655200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.770400E-01 |
| Classical-VS-Follicular |
4.184000E-02 |
| Classical-VS-Other |
7.014800E-01 |
| Classical-VS-Normal |
9.96339677428182E-11 |
| Tall-VS-Follicular |
4.899400E-01 |
| Tall-VS-Other |
4.888600E-01 |
| Tall-VS-Normal |
1.831670E-04 |
| Follicular-VS-Other |
3.492800E-01 |
| Follicular-VS-Normal |
5.961500E-03 |
| Other-VS-Normal |
7.017500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89900000169274E-08 |
| Normal-vs-N1 |
1.244400E-04 |
| N0-vs-N1 |
4.408800E-01 |
|
|
